Ledger.Open graph →
SEC Form D · filed November 24, 2015

Adgero Biopharmaceuticals Holdings, Inc

Offering
$50K
Sold
$40K
Exemption
Rule 506(b)
Industry
Investing
Location
NEW YORK, NY
Type
—

Rule 506(b): private placement to accredited investors, no public advertising.

People & firms on this filing (5)

David Hochman · New York, NYExec · DirectorJohn Brancaccio · New York, NYExecPaul Coviello · ASHEVILLE, NCExecPaul Cox · ASHEVILLE, NCExec · DirectorRandy Williams · SEATTLE, WAExec · Director

Public SEC Form D (Reg D) filing. · View issuer on SEC EDGAR ↗